MAP3K15 and diabetes mellitus: Recessive carriers of nonsynonymous variants in MAP3K15 were 30% less likely to develop diabetes (P = 5.7 × 10−10) and had lower glycosylated hemoglobin (β = −0.14 SD units, P = 1.1 × 10−24).